This latest conference addressed a number of important issues. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to additional progress in the future.
New York, New York (PRWEB) July 01, 2013
Hundreds of Biomet hip lawsuits involving the Biomet M2a Magnum Hip Replacement System continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on June 24th, the Biomet hip replacement litigation’s most recent case management conference was held on June 17, 2013, at which time a number of issues were addressed, including pending motions to strike affirmative defenses, jurisdictional issues related to the recent dismissal of improperly named defendants, and the use of a form complaint. At the conclusion of the conference, the parties presented a tutorial on the scientific and technical issues involved in the Biomet hip replacement lawsuits. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“This latest conference addressed a number of important issues. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to additional progress in the future,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is representing clients in Biomet hip lawsuits in the federal multidistrict litigation, and continues to offer free and confidential case evaluations to individuals who may have been injured by Biomet M2a Magnum implants.
Biomet Hip Replacement Lawsuits
Court documents indicate that more than 300 Biomet hip lawsuits are now pending in the federal multidistrict litigation. All of the claims allege the Biomet M2a Magnum implant’s metal-on-metal design can shed dangerous amounts of toxic metal debris as a result of wear, leading to metallosis and other adverse tissue reactions, as well as premature device failure. According to the June 17th Memorandum, the Biomet hip replacement litigation’s next case management conference has been scheduled for September 23, 2013, while a telephonic status conference is set for July 29, 2013.
The U.S. Food & Drug Administration (FDA) has been reviewing the safety of metal-on-metal hip implants like the Biomet M2a Magnum since February 2011. In January, the FDA warned that the metal debris shed from these devices can cause damage to bone and/or tissue surrounding the implant and joint, leading to pain, implant loosening, device failure, and the need for revision surgery to replace the device. At that time, the agency advised recipients of metal-on-metal hip replacements to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market without first undergoing human clinical trials.*
Alleged victims of metal-on-metal hip implant complications related to the Biomet M2a Magnum hip may be entitled to compensation for their medical expenses, lost wages and pain and suffering. To learn more about the Biomet hip replacement litigation, please visit Bernstein Liebhard LLP’s website. For additional information about filing a Biomet hip lawsuit, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP